Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gloria, Herzog"'
Autor:
Simon Kloock, Niklas Haerting, Gloria Herzog, Marie Oertel, Niklas Geiger, Andreas Geier, Vasco Sequeira, Alexander Nickel, Michael Kohlhaas, Martin Fassnacht, Ulrich Dischinger
Publikováno v:
Nutrients, Vol 16, Iss 6, p 904 (2024)
(1) Background: Modulators of the Neuropeptide Y (NPY) system are involved in energy metabolism, but the effect of NPY receptor antagonists on metabolic-dysfunction-associated steatotic liver disease (MASLD), a common obesity-related comorbidity, are
Externí odkaz:
https://doaj.org/article/1e67dd15c82a4fa68d2d9694b48d0915
Autor:
Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 3, p 753 (2022)
Background: Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements
Externí odkaz:
https://doaj.org/article/be3aa6f0497e454d98f9798cf8a1269f
Autor:
Niklas Haerting, Gloria Herzog, Alexander Nickel, Michael Kohlhaas, Martin Fassnacht, Christian Ziegler, Ulrich Dischinger
Publikováno v:
Endocrine Abstracts.
Autor:
Valentin, Metzner, Gloria, Herzog, Tobias, Heckel, Thorsten, Bischler, Julia, Hasinger, Christoph, Otto, Martin, Fassnacht, Andreas, Geier, Florian, Seyfried, Ulrich, Dischinger
Publikováno v:
Journal of clinical medicine. 11(3)
Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements in phase 2